Lv4
480 积分 2023-08-09 加入
Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy - a post-hoc analysis
2天前
已完结
Structure of the IgY-FcRY complex and its comparison with IgG-FcRn
2天前
待确认
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
4天前
已完结
Early versus escalation treatment of tocilizumab in neuromyelitis optica spectrum disorder: a retrospective study
4天前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
4天前
已完结
Interleukin-6 in neuroimmunological disorders: Pathophysiology and therapeutic advances with satralizumab
4天前
已完结
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody–associated disease
4天前
已完结
Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD)
6天前
已完结
Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data
6天前
已完结
皖公网安备34019202002308
